Sarepta Therapeutics Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| PFE | Pfizer | Outperform |
2
|
$27.81 | $32.87 | 9.67% | 6 | $157.48B |
| SAN | Sanofi | Outperform |
16
|
91.30€ | 102.80€ | 19.39% | 9 | 114.00€B |
| 4568 | Daiichi Sankyo Company | Buy |
4
|
¥5.50k | ¥5.24k | 5.42% | 0 | ¥10.55T |
| MRNA | Moderna | Outperform |
16
|
$125.00 | $135.42 | 1.12% | 1 | $47.90B |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.13k | ¥4.74k | 10.30% | 0 | ¥6.47T |
| BIIB | Biogen | Outperform |
10
|
$217.51 | $299.62 | 32.64% | 13 | $31.67B |
| ALNY | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$152.33 | $245.24 | 42.78% | 7 | $19.27B |
| BAX | Baxter International Inc | Outperform |
17
|
$36.89 | $44.86 | 19.27% | 5 | $18.80B |
| BMRN | BioMarin Pharmaceutical | Outperform |
10
|
$82.44 | $111.56 | 33.43% | 5 | $15.65B |
| IONS | Ionis Pharmaceuticals | Outperform |
9
|
$41.97 | $55.60 | 42.96% | 3 | $6.12B |
| DYN | Dyne Therapeutics | Buy |
5
|
$26.08 | $28.13 | 39.95% | 0 | $2.24B |
| DCPH | Deciphera Pharmaceuticals | Outperform |
6
|
$25.38 | $23.40 | 0.87% | 4 | $2.09B |
| 4516 | Nippon Shinyaku | Outperform |
18
|
¥4.39k | ¥8.34k | 48.10% | 0 | ¥293.93B |
| WVE | Wave Life Sciences | Outperform |
6
|
$6.14 | $9.21 | 119.87% | 3 | $602.86M |
| STOK | Stoke Therapeutics | Buy |
4
|
$12.02 | $19.33 | 74.71% | 3 | $574.86M |
| ABUS | Arbutus Biopharma | Outperform |
9
|
$2.71 | $6.34 | 102.21% | 0 | $511.42M |
| FULC | Fulcrum Therapeutics | Outperform |
9
|
$7.75 | $10.21 | 87.10% | 7 | $443.16M |
| PYC | PYC Therapeutics | Buy |
8
|
$0.11 | $0.30 | 227.27% | 1 | $294.90M |
| AIM | AIM ImmunoTech | Buy |
0
|
$0.40 | $3.83 | 775.00% | 0 | $23.20M |